Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Pfizer Chief Scientific Officer Dr Mikael Dolsten to depart

Ruchika Sharma10 July 2024 2:30 PM IST

New York: Pfizer Inc. has announced that Dr. Mikael Dolsten, Pfizer's Chief Scientific Officer and President, Pfizer Research & Development,...

No Waiver for Faricimab: CDSCO Panel Asks Roche to Conduct Phase III Trial in India

Roche receives CE Mark for AI-enabled continuous glucose monitoring solution for diabetes patients

Ruchika Sharma10 July 2024 12:30 PM IST

Basel: Roche has announced that it has received the CE Mark for its Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution. This paves...

Shilpa Medicare Dabaspet unit gets VAI classification from USFDA

Shilpa Medicare arm Raichur API facility gets GMP Certification from ANVISA-Brazil

Ruchika Sharma10 July 2024 11:31 AM IST

Karnataka: Shilpa Medicare Limited's 100 percent subsidiary, Shilpa Pharma Lifesciences Limited's Active Pharmaceutical Ingredient (API)...

Darzalex receives positive EMA Committee opinion for high-risk smouldering multiple myeloma: Janssen-Cilag International

COVID vaccine supply deal dispute: JnJ to pay USD 50 million to Emergent

Ruchika Sharma9 July 2024 5:49 PM IST

Emergent BioSolutions has said that Johnson & Johnson has agreed to settle claims arising from the termination of the manufacturing deal for the...

Alembic Pharma bags USFDA nod for Bromfenac Ophthalmic Solution

Ruchika Sharma9 July 2024 2:47 PM IST

Vadodara: Alembic Pharmaceuticals Limited has announced that the Company has received final approval from the US Food & Drug Administration...

Roche receives EU CE mark for Contivue for neovascular age-related macular degeneration

Roche to reintroduce Susvimo in US for neovascular age-related macular degeneration

Ruchika Sharma9 July 2024 1:00 PM IST

Basel: Roche has announced the reintroduction of Susvimo (ranibizumab injection) 100 mg/mL for intravitreal use via ocular implant for the...

Eli Lilly gets USFDA Breakthrough Therapy designation for olomorasib with Keytruda for lung cancer

Eli Lilly to acquire Morphic for USD 3.2 billion

Ruchika Sharma9 July 2024 11:28 AM IST

Indianapolis: Eli Lilly and Company and Morphic Holding, Inc. have announced a definitive agreement for Lilly to acquire Morphic, a...

Roche to halt lung cancer treatment trial

Ruchika Sharma8 July 2024 5:43 PM IST

Based on these results, patients and investigators will be unblinded and we intend to halt the study.

G Kishan Reddy says Centre will try its best to promote pharma sector in Hyderabad

Ruchika Sharma8 July 2024 5:10 PM IST

Hyderabad: The Pharma sector should be encouraged and government in the coming days will try its best to promote the sector, said Union Minister...

Indian pharma firms seek tax incentives to boost innovation

Ruchika Sharma8 July 2024 4:10 PM IST

As India anticipates Prime Minister Narendra Modi's government to present the federal finance budget in July, pharmaceutical companies in the country...

Biocon appoints Ekta Agarwal as Interim Company Secretary, Compliance Officer

Biocon Biologics plans to raise Rs 4,000-4,500 crore via local bonds: Report

Ruchika Sharma8 July 2024 12:30 PM IST

Biocon Biologics Ltd., a biopharmaceutical company, is considering raising between Rs 4,000 crore and Rs 4,500 crore from India’s local-currency bond...

AstraZeneca Gets SEC Approval to Conduct Phase IV Trial of Hyperkalemia Drug Sodium Zirconium Cyclosilicate

AstraZeneca Tagrisso plus chemotherapy approved in EU for EGFR-mutated advanced lung cancer

Ruchika Sharma8 July 2024 11:30 AM IST

Cambridge: AstraZeneca has announced that Tagrisso (osimertinib) with the addition of pemetrexed and platinum-based chemotherapy has been...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok